Table 3 Patient Outcomes
Total (n = 238) | Early discharge (n = 138) | Admission avoidance (n = 100) | |
|---|---|---|---|
Primary outcomes | |||
Escalation to hospital, n(%) | 41 (17.2) | 22 (15.9) | 19 (19.0) |
COVID-related escalation, n(%) | 24 (10.1) | 15 (10.8) | 9 (9) |
Mortality, n(%) | 5 (2.1) | 3 (2.1) | 2 (2.0) |
Secondary outcomes | |||
Reason for escalation, n(%) | |||
Hypoxia | 14 (34.1) | 9 (40.9) | 5 (26.3) |
COVID, non-hypoxic | 10 (24.4) | 6 (27.3) | 4 (21.1) |
Non-COVID medical condition | 10 (24.4) | 5 (22.7) | 5 (26.3) |
For monoclonals | 4 (9.89) | 2 (9.1) | 2 (10.5) |
Others | 3 (7.3) | 0 | 3 (15.8) |
Outcome of escalation, n(%) | |||
Returned to virtual ward | 13 (31.7) | 9 (40.9) | 4 (21.2) |
Ward admission & recovered | 19 (46.3) | 10 (45.4) | 9 (47.3) |
ICU admission & recovered | 4 (9.7) | 1 (4.5) | 3 (15.8) |
Death | 3 (7.3) | 2 (9.1) | 1 (5.2) |
Unknown | 2 (4.8) | 0 | 2 (10.5) |